Emory University and Micron Biomedical launch first-in-human clinical trial of next-generation rotavirus vaccine delivered via dissolvable microarray technology
Business Announcement
Updates every hour. Last Updated: 20-Jun-2025 10:10 ET (20-Jun-2025 14:10 GMT/UTC)
Research builds on Emory’s research on influenza vaccines self-administered via Micron’s microarray technology. This trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology.
MIT researchers built an ultrasmall, low-power receiver that is designed to block a certain type of interference. The chip could be utilized in 5G-enabled smart devices that would be smaller, have longer battery lives, and be more reliable in crowded radio environments.
In a new study, researchers from Boston University Chobanian & Avedisian School of Medicine, Massachusetts General Hospital (MGH) and Harvard Medical School, identified several uncharacterized chromatin factors (proteins that regulate gene expression) that are recruited to sites of DNA damage, including the gene ZNF280A. Importantly, this gene is hemizygously deleted – meaning one of the two copies of alleles is missing—in a subset of patients with a human developmental syndrome called 22q11.2 distal deletion syndrome.
Simultaneously detecting multiple signals with high precision has long challenged microelectromechanical systems (MEMS) sensors due to unavoidable interference.